LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 132c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q1 EPS of ($1.32). Revenue for the quarter came in at $1.9 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS cuts gold price forecasts on delayed Fed easing outlook
• Guggenheim Reiterates Buy Rating on StubHub Holdings (STUB)